-
Analyst Opinions
NewScrutinizing Ultra-Processed Foods (UPFs) – Industry Insights
This report is part of a series on key trends and issues that are currently affecting the consumer landscape in consumer goods, foodservice, and packaging. It explains what an ultra processed food is, how consumers are responding to this new categorization, and how brands can tackle this issue in formulation and marketing. Debate around UPFs is still fresh with new evidence and research still being released. Government regulation and the influence of the media on consumer shopping decisions make it...
-
Product Insights
NewLikelihood of Approval Analysis for Ductal Carcinoma
Overview How likely is it that the drugs in Ductal Carcinoma will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Ductal Carcinoma Overview Ductal Carcinoma is early stage of breast cancer where...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Dapansutrile in Osteoarthritis Pain
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Dapansutrile in Osteoarthritis Pain report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Dapansutrile in Osteoarthritis Pain Drug Details: Dapansutrile (OLT-1177) is under development for...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Dapansutrile in Systolic Heart Failure
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Dapansutrile in Systolic Heart Failure report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Dapansutrile in Systolic Heart Failure Drug Details: Dapansutrile (OLT-1177) is under...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Divozilimab in Neuromyelitis Optica (Devic’s Syndrome)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Divozilimab in Neuromyelitis Optica (Devic's Syndrome) report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Divozilimab in Neuromyelitis Optica (Devic's Syndrome) Drug Details: Divozilimab (Ivlizi)...
-
Thematic Analysis
NewRobotics in Construction – Thematic Intelligence
Robotics in Construction Thematic Intelligence Report Overview The construction industry has been generally slow to digitalize and adopt new technologies. As an industry, it relies heavily on manual labor resulting in low productivity growth. Adopting robots can increase safety on construction sites, ensure projects are delivered on time, and help maintain productivity. As costs decrease and the benefits become increasingly evident, construction companies will implement more robots across the ecosystem. The ‘Robotics in Construction’ thematic intelligence report assesses how robotics...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – (Sacubitril + Valsartan) in Hypertrophic Cardiomyopathy
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - (Sacubitril + Valsartan) in Hypertrophic Cardiomyopathy report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. (Sacubitril + Valsartan) in Hypertrophic Cardiomyopathy Drug Details: Sacubitril and...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Golimumab in Type 1 Diabetes (Juvenile Diabetes)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Golimumab in Type 1 Diabetes (Juvenile Diabetes) report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Golimumab in Type 1 Diabetes (Juvenile Diabetes) Drug...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Golimumab in Castration-Resistant Prostate Cancer (CRPC)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Golimumab in Castration-Resistant Prostate Cancer (CRPC) report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Golimumab in Castration-Resistant Prostate Cancer (CRPC) Drug Details: Golimumab...